Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen Effects on Brain Function
NCT02507219Phase 3Completed
- Start
- Jul 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen in major depressive disorder (MDD) (3 arms). Primary endpoint: Dose-dependent Differences in the BOLD Response to fMRI Tasks in the Amygdala. Started Jul 2015; status: completed.
02
Drugs
ibuprofen
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02507219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02507219.